IGF1 and retinopathy of prematurity: In phase 2 or the proliferative phase of ROP, increased metabolic activity of the maturing retina leads to relative hypoxia and increased production of VEGF-A as well as other angiogenic factors, such as insulin-like growth factor 1 (IGF-1) and erythropoietin (EPO).